Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.55B |
| 2 |
Apple
AAPL
|
+$341M |
| 3 |
NVIDIA
NVDA
|
+$216M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$112M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$73.4M |
| 2 |
SNDK
Sandisk
SNDK
|
+$70.1M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$55.2M |
| 4 |
Amazon
AMZN
|
+$44.8M |
| 5 |
HI
Hillenbrand
HI
|
+$39.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.31% |
| 2 | Industrials | 11.45% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 7.44% |
| 5 | Financials | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Rogers Corp
ROG
$2.26B
| $872K | ﹤0.01% |
8,124
-4,309
| -35% | -$443K |
|
|
TERN
1352
DELISTED
Terns Pharmaceuticals
TERN
| $870K | ﹤0.01% |
16,497
+5,021
| +44% | +$206K |
|
1353
Flywire
FLYW
$2.38B
| $868K | ﹤0.01% |
74,591
+3,306
| +5% | +$41.6K |
|
1354
NETSCOUT
NTCT
$2.8B
| $866K | ﹤0.01% |
27,255
-9,605
| -26% | -$279K |
|
1355
Brink's
BCO
$4.59B
| $862K | ﹤0.01% |
8,322
+2,002
| +32% | +$240K |
|
1356
DoubleLine Opportunistic Bond ETF
DBND
$754M
| $862K | ﹤0.01% |
18,823
| – | – |
|
1357
Ares Management
ARES
$31.9B
| $857K | ﹤0.01% |
7,851
+4,880
| +164% | +$647K |
|
1358
Monarch Casino & Resort
MCRI
$2.26B
| $850K | ﹤0.01% |
8,889
+3,333
| +60% | +$317K |
|
1359
Prestige Consumer Healthcare
PBH
$2.43B
| $848K | ﹤0.01% |
14,315
-9,856
| -41% | -$639K |
|
1360
Progress Software
PRGS
$1.82B
| $847K | ﹤0.01% |
33,004
-1,151
| -3% | -$44K |
|
1361
Travere Therapeutics
TVTX
$6.19B
| $843K | ﹤0.01% |
28,377
-27,607
| -49% | -$825K |
|
1362
iShares Russell 2000 Value ETF
IWN
$14.6B
| $843K | ﹤0.01% |
4,445
+3,012
| +210% | +$583K |
|
1363
Ligand Pharmaceuticals
LGND
$5.71B
| $833K | ﹤0.01% |
4,172
-5,174
| -55% | -$1.02M |
|
1364
ESAB
ESAB
$5.06B
| $831K | ﹤0.01% |
8,601
-473
| -5% | -$54.8K |
|
1365
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $831K | ﹤0.01% |
16,639
+5,097
| +44% | +$253K |
|
|
BORR
1366
Borr Drilling
BORR
$1.39B
| $827K | ﹤0.01% |
143,372
+21,496
| +18% | +$110K |
|
1367
NCR Voyix
VYX
$1.09B
| $827K | ﹤0.01% |
130,634
+15,593
| +14% | +$138K |
|
1368
Minerals Technologies
MTX
$2.21B
| $817K | ﹤0.01% |
11,525
-316
| -3% | -$21.7K |
|
1369
Trinity Capital Inc
TRIN
$1.74B
| $816K | ﹤0.01% |
55,455
+5,455
| +11% | +$84.3K |
|
1370
Invesco S&P 500 Momentum ETF
SPMO
$22.1B
| $810K | ﹤0.01% |
+7,228
| New | +$854K |
|
1371
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.25B
| $809K | ﹤0.01% |
22,730
| – | – |
|
1372
Cheesecake Factory
CAKE
$5.64B
| $809K | ﹤0.01% |
14,768
+9,129
| +162% | +$544K |
|
1373
Capital Group US Multi-Sector Income ETF
CGMS
$5.43B
| $801K | ﹤0.01% |
29,430
| – | – |
|
1374
Badger Meter
BMI
$3.82B
| $791K | ﹤0.01% |
5,191
+2,079
| +67% | +$326K |
|
1375
Dycom Industries
DY
$11.8B
| $786K | ﹤0.01% |
2,321
-12,966
| -85% | -$4.87M |
|
Similar funds
Joel Greenblatt's Q1 2026 Portfolio in Review
As of Q1 2026, Joel Greenblatt held 1,878 positions worth $32.7B, up 19% from $27.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Joel Greenblatt deployed $5.65B of net new capital in Q1 2026, opening 159 new positions and adding to 937 existing holdings. Its largest new stake was iShares Russell 3000 ETF: 288,620 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $73.4M trimmed.
- Joel Greenblatt's largest Q1 2026 buy was iShares Russell 3000 ETF: 288,620 shares worth $107M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $1.55B increase.
- Joel Greenblatt's biggest Q1 2026 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $73.4M.
- Joel Greenblatt fully exited Hillenbrand in Q1 2026, selling an estimated $39.3M.
- Joel Greenblatt's ten largest holdings make up 28% of its $32.7B portfolio in Q1 2026.
- Joel Greenblatt opened 159 new positions and closed 129 in Q1 2026.
- Joel Greenblatt's portfolio value rose 19% quarter-over-quarter to $32.7B.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.